Status:
COMPLETED
Predict Transpulmonary Pressure Through ZAM
Lead Sponsor:
Southeast University, China
Conditions:
Acute Respiratory Failure
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Stable patient with ARF spontaneously breathing light sedation (not too awake but with stable breathing pattern) and EAdi \>8 uV. Four modes of mechanical ventilation were performed under different su...
Detailed Description
1. Mode NAVA spontaneous breathing select a NAVA level that gives peak pressure about 9-10 cm H2O assist keep NAVA level for 15 minutes, do ZAM breaths every 3 minutes (make sure not to disturb the pa...
Eligibility Criteria
Inclusion
- Stable patient with acute respiratory failure on invasive mechanical ventilation Can tolerate pressure support ventilation light sedation with RASS between -2 and 1
Exclusion
- EAdi\<8 uV contraindication for nasogastric tube insertion neuromuscular disease affecting spontaneous breathing lack of informed consent, and patients included in other intervention study
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 10 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05378802
Start Date
November 1 2021
End Date
August 10 2023
Last Update
August 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongda hospital, Southeast university
Nanjing, Jiangsu, China, 210009